UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Selective inhibition of eosinophil influx into the lung by small molecule CC chemokine receptor 3 antagonists in mouse models of allergic inflammation

The Journal of pharmacology and experimental therapeutics, 2006-07, Vol.318 (1), p.411-417

2006

Volltextzugriff (PDF)

Enhancements in the world of digital forensics

IAES international journal of artificial intelligence, 2024-03, Vol.13 (1), p.680

2024

Volltextzugriff (PDF)

A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1′ group for the β-amino hydroxamic acid derived TACE inhibitors

Bioorganic & medicinal chemistry letters, 2007-04, Vol.17 (7), p.1865-1870

2007

Volltextzugriff (PDF)

CC chemokine receptor-3 (CCR3) antagonists: Improving the selectivity of DPC168 by reducing central ring lipophilicity

Bioorganic & medicinal chemistry letters, 2007-06, Vol.17 (11), p.2992-2997

2007

Volltextzugriff (PDF)

Comparison of biological responses of human monocytes and THP-1 cells to chemokines of the intercrine-beta family

Journal of leukocyte biology, 1994-06, Vol.55 (6), p.756-762

1994

Volltextzugriff (PDF)

Successful management of a cutaneous abscess caused by Candida albicans in a very low birth weight neonate

Journal of clinical neonatology, 2022-10, Vol.11 (4), p.219-221

2022

Volltextzugriff (PDF)

A Quality Improvement Initiative to Increase the Milk Donation to the Human Milk Bank Post-Coronavirus Disease-19 Pandemic

Breastfeeding medicine, 2023-11, Vol.18 (11), p.864-869

2023

Volltextzugriff (PDF)

Knowledge, Attitude and Practice (KAP) Study of Pediatricians on Infantile Spasms

Indian journal of pediatrics, 2018-10, Vol.85 (10), p.836-840

2018

Volltextzugriff (PDF)

Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-α converting enzyme (TACE): Discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1′ substituents

Bioorganic & medicinal chemistry, 2008-03, Vol.18 (6), p.1958-1962

2008

Volltextzugriff (PDF)

Review of West Syndrome: Concerns on Optimum Dose of Adrenocorticotrophic Hormone

Clinical drug investigation, 2018-06, Vol.38 (6), p.563-564

2018

Volltextzugriff (PDF)

Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents

Bioorganic & medicinal chemistry, 2008-03, Vol.18 (5), p.1577-1582

2008

Volltextzugriff (PDF)

Regulation of monocyte integrin expression by beta-family chemokines

The Journal of immunology (1950), 1994-11, Vol.153 (10), p.4721-4732

1994

Volltextzugriff (PDF)

α,β-Cyclic-β-benzamido hydroxamic acids: Novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-α converting enzyme (TACE)

Bioorganic & medicinal chemistry, 2008-01, Vol.18 (2), p.694-699

2008

Volltextzugriff (PDF)

Discovery of β-benzamido hydroxamic acids as potent, selective, and orally bioavailable TACE inhibitors

Bioorganic & medicinal chemistry, 2008, Vol.18 (1), p.241-246

2008

Volltextzugriff (PDF)

Synthesis and structure–activity relationship of a novel, achiral series of TNF-α converting enzyme inhibitors

Bioorganic & medicinal chemistry letters, 2006-05, Vol.16 (10), p.2699-2704

2006

Volltextzugriff (PDF)

chemokine factsbook

1997

Volltextzugriff (PDF)

α,β-Cyclic-β-benzamido hydroxamic acids: Novel oxaspiro[4.4]nonane templates for the discovery of potent, selective, orally bioavailable inhibitors of tumor necrosis factor-α converting enzyme (TACE)

Bioorganic & medicinal chemistry, 2008-02, Vol.18 (4), p.1288-1292

2008

Volltextzugriff (PDF)

Transgenic animals in inflammatory disease models

Current opinion in biotechnology, 2003-12, Vol.14 (6), p.652-658

2003

Volltextzugriff (PDF)

MODULATION OF MACROPHAGE ACTIVATION BY AMMONIUM METAVANADATE

Journal of toxicology and environmental health, 1996-12, Vol.49 (6), p.631-645

1996

Volltextzugriff (PDF)

Synthesis and structure–activity relationship of a novel sulfone series of TNF-α converting enzyme inhibitors

Bioorganic & medicinal chemistry letters, 2004-09, Vol.14 (17), p.4453-4459

2004

Volltextzugriff (PDF)

Potent, exceptionally selective, orally bioavailable inhibitors of TNF-α Converting Enzyme (TACE): Novel 2-substituted-1 H-benzo[ d]imidazol-1-yl)methyl)benzamide P1′ substituents

Bioorganic & medicinal chemistry letters, 2008, Vol.18 (5), p.1577-1582

2008

Volltextzugriff (PDF)

Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-a converting enzyme (TACE) : Discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents

Bioorganic & medicinal chemistry letters, 2008, Vol.18 (6), p.1958-1962

2008

Volltextzugriff (PDF)

Potent, exceptionally selective, orally bioavailable inhibitors of TNF-α Converting Enzyme (TACE) : Novel 2-substituted-1H-benzo[d]imidazol-1-ylmethylbenzamide P1' substituents

Bioorganic & medicinal chemistry letters, 2008, Vol.18 (5), p.1577-1582

2008

Volltextzugriff (PDF)

Α,β -Cyclic-β -benzamido hydroxamic acids : Novel oxaspiro[4.4]nonane templates for the discovery of potent, selective, orally bioavailable inhibitors of tumor necrosis factor-a converting enzyme (TACE)

Bioorganic & medicinal chemistry letters, 2008, Vol.18 (4), p.1288-1292

2008

Volltextzugriff (PDF)

Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-α converting enzyme inhibitors. Part 2: Lead optimization

Bioorganic & medicinal chemistry letters, 2003-12, Vol.13 (24), p.4299-4304

2003

Volltextzugriff (PDF)

1 – 25 von 104

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(37)

Publikationsform

Sprache

Englisch
(104)

Erscheinungsjahr

n.n

Thema

Science & Technology
(31)
Life Sciences & Biomedicine
(26)
Animals
(15)
Biological And Medical Sciences
(14)
Humans
(14)
Medical Sciences
(13)
Pharmacology & Pharmacy
(12)
Physical Sciences
(12)
Chemistry
(11)
Pharmacology. Drug Treatments
(10)
Adam17 Protein
(9)
Chemistry, Medicinal
(9)
Chemistry, Organic
(9)
Immunology
(9)
Mice
(9)
Structure-Activity Relationship
(8)
Adam Proteins - Antagonists & Inhibitors
(7)
Bones, Joints And Connective Tissue. Antiinflammatory Agents
(7)
Rats
(7)
Biological Availability
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Selective inhibition of eosinophil influx into the lung by small molecule CC chemokine receptor 3 antagonists in mouse models of allergic inflammation

Enhancements in the world of digital forensics

A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1′ group for the β-amino hydroxamic acid derived TACE inhibitors

CC chemokine receptor-3 (CCR3) antagonists: Improving the selectivity of DPC168 by reducing central ring lipophilicity

Comparison of biological responses of human monocytes and THP-1 cells to chemokines of the intercrine-beta family

Successful management of a cutaneous abscess caused by Candida albicans in a very low birth weight neonate

A Quality Improvement Initiative to Increase the Milk Donation to the Human Milk Bank Post-Coronavirus Disease-19 Pandemic

Knowledge, Attitude and Practice (KAP) Study of Pediatricians on Infantile Spasms

Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-α converting enzyme (TACE): Discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1′ substituents

Review of West Syndrome: Concerns on Optimum Dose of Adrenocorticotrophic Hormone

Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents

Regulation of monocyte integrin expression by beta-family chemokines

α,β-Cyclic-β-benzamido hydroxamic acids: Novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-α converting enzyme (TACE)

Discovery of β-benzamido hydroxamic acids as potent, selective, and orally bioavailable TACE inhibitors

Synthesis and structure–activity relationship of a novel, achiral series of TNF-α converting enzyme inhibitors

chemokine factsbook

α,β-Cyclic-β-benzamido hydroxamic acids: Novel oxaspiro[4.4]nonane templates for the discovery of potent, selective, orally bioavailable inhibitors of tumor necrosis factor-α converting enzyme (TACE)

Transgenic animals in inflammatory disease models

MODULATION OF MACROPHAGE ACTIVATION BY AMMONIUM METAVANADATE

Synthesis and structure–activity relationship of a novel sulfone series of TNF-α converting enzyme inhibitors

Potent, exceptionally selective, orally bioavailable inhibitors of TNF-α Converting Enzyme (TACE): Novel 2-substituted-1 H-benzo[ d]imidazol-1-yl)methyl)benzamide P1′ substituents

Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-a converting enzyme (TACE) : Discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents

Potent, exceptionally selective, orally bioavailable inhibitors of TNF-α Converting Enzyme (TACE) : Novel 2-substituted-1H-benzo[d]imidazol-1-ylmethylbenzamide P1' substituents

Α,β -Cyclic-β -benzamido hydroxamic acids : Novel oxaspiro[4.4]nonane templates for the discovery of potent, selective, orally bioavailable inhibitors of tumor necrosis factor-a converting enzyme (TACE)

Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-α converting enzyme inhibitors. Part 2: Lead optimization

Suchergebnisse filtern